Academic Journal
The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review
العنوان: | The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review |
---|---|
المؤلفون: | Belkouche, Alban, Yao, Hermann, Putot, Alain, Chagué, Frédéric, Rochette, Luc, Danchin, Nicolas, Zeller, Marianne, Cottin, Yves |
المساهمون: | Service de Cardiologie CHU de Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Physiopathologie et épidémiologie cérébro-cardiovasculaire Dijon (PEC2), Université de Bourgogne (UB)-Université Bourgogne Franche-Comté COMUE (UBFC), Hôpital Européen Georges Pompidou APHP (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO) |
المصدر: | ISSN: 2077-0383 ; Journal of Clinical Medicine ; https://hal.science/hal-03656004 ; Journal of Clinical Medicine, 2021, 10 (2), pp.198. ⟨10.3390/jcm10020198⟩. |
بيانات النشر: | CCSD MDPI |
سنة النشر: | 2021 |
المجموعة: | Université de Bourgogne (UB): HAL |
مصطلحات موضوعية: | atrial fibrillation, bleeding, chronic coronary syndrome, type 1 and type 2 myocardial infarction, [SHS]Humanities and Social Sciences |
الوصف: | International audience ; This review was conducted to emphasize the complex interplay between atrial fibrillation (AF) and myocardial infraction (MI). In type 1 (T1) MI, AF is frequent and associated with excess mortality. Moreover, AF after hospital discharge for T1MI is not rare, suggesting the need to improve AF screening and to develop therapeutic strategies for AF recurrence. Additionally, AF is a common trigger for type 2 MI (T2MI), and recent data have shown that tachyarrhythmia or bradyarrhythmia could be a causal factor in, respectively, 13–47% or 2–7% of T2MI. In addition, AF is involved in T2MI pathogenesis as a result of severe anemia related to anticoagulants. AF is also an underestimated and frequent cause of coronary artery embolism (CE), as a situation at risk of myocardial infarction with non-obstructive coronary arteries. AF-causing CE is difficult to diagnose and requires specific management. Moreover, patients with both AF and chronic coronary syndromes represent a therapeutic challenge because the treatment of AF include anticoagulation, depending on the embolic risk, and ischemic heart disease management paradoxically includes antiplatelet therapy. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
Relation: | info:eu-repo/semantics/altIdentifier/pmid/33430505; PUBMED: 33430505; PUBMEDCENTRAL: PMC7826531 |
DOI: | 10.3390/jcm10020198 |
الاتاحة: | https://hal.science/hal-03656004 https://hal.science/hal-03656004v1/document https://hal.science/hal-03656004v1/file/jcm-10-00198-v2.pdf https://doi.org/10.3390/jcm10020198 |
Rights: | info:eu-repo/semantics/OpenAccess |
رقم الانضمام: | edsbas.66D95DE9 |
قاعدة البيانات: | BASE |
DOI: | 10.3390/jcm10020198 |
---|